Government
FDA RECALL: Mirabegron Tablets Pulled Over Impurity Concern
The FDA has issued a Class II recall for one lot of mirabegron extended‑release 25 mg tablets, a prescription medication used to treat overactive bladder. The recall was initiated after testing detected an N‑nitroso impurity […]